Fig. 4
JMJD6 overexpression or impairment of the p53 pathway potentiates NPC cell proliferation and migration. A, The expression of p-p53 and p53 proteins in cells after PFTα treatment, and the grayscale values of the target bands (p-p53 or p53) were detected by ImageJ software before being normalized using the grayscale values of the internal reference band GAPDH (n = 3, analyzed by the two-way ANOVA, **represents p < 0.01, ****represents p < 0.0001). B, The cell migration was assessed by Transwell assay, and the number of cells migrated to the basolateral chamber was detected after 24 h of incubation. Five nonoverlapping fields were selected to observe the cells and calculate the mean number of migrated cells (n = 3, analyzed by the two-way ANOVA, **** represents p < 0.0001). C, Wound healing assay was performed to detect the migration ability of cells and wound width was measured at 0 and 48 h to calculate the 48-h migration rate of cells (n = 3, analyzed by the two-way ANOVA, ***represents p < 0.001, ****represents p < 0.0001). D, The OD at 450 nm was measured at 0 h, 24 h, 48 h, and 72 h of cell growth, thus assessing the proliferative capacity of cells (n = 3, analyzed by the two-way ANOVA, *represents p < 0.05, ***represents p < 0.001, ****represents p < 0.0001). E, The effect of PFTα treatment on the proliferative activity of NPC cells was detected by colony formation assays, and the number of colonies was counted under the microscope after 10 days of routine cell culture (n = 3, analyzed by the two-way ANOVA, *represents p < 0.05, **represents p < 0.01, ***represents p < 0.001, ****represents p < 0.0001). F, Cells were stained with PI for 30 min and subsequently analyzed by flow cytometry for changes in the NPC cell cycle caused by inhibition of CCNB2. PI fluorescence intensity directly reflected intracellular DNA content, and cells were classified according to DNA content into G1/G0, G2/M phase, and S phase. The percentage of cells in each phase corresponding to the flow histogram was calculated by FlowJo X software (n = 3, analyzed by the two-way ANOVA, *represents p < 0.05, **represents p < 0.01, ***represents p < 0.001, ****represents p < 0.0001). G, The expression of CCNB2 and EMT-related protein after PFTα treatment analyzed using western blot assays and ImageJ software (normalized to GAPDH) (n = 3, analyzed by the two-way ANOVA, ***represents p < 0.001, ****represents p < 0.0001). Data are represented as mean ± SD.